SG/CALL/SANZ GROUPAR/38/0.1/21.03.25 Share Price

Warrant

DE000SU9GNE6

Market Closed - Boerse Frankfurt Warrants 20:36:40 14/06/2024 BST
0.13 EUR 0.00% Intraday chart for SG/CALL/SANZ GROUPAR/38/0.1/21.03.25
Current month-7.14%
1 month-13.33%
Date Price Change
14/06/24 0.13 0.00%
13/06/24 0.13 +8.33%
12/06/24 0.12 +9.09%
11/06/24 0.11 -8.33%
10/06/24 0.12 -14.29%

Real-time Boerse Frankfurt Warrants

Last update June 14, 2024 at 08:36 pm

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying SANDOZ GROUP AG
IssuerLogo Issuer Société Générale Société Générale
WKN SU9GNE
ISINDE000SU9GNE6
Date issued 16/02/2024
Strike 38 CHF
Maturity 21/03/2025 (278 Days)
Parity 10 : 1
Emission price 0.12
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.17
Lowest since issue 0.018
Spread 0.02
Spread %13.33%

Company Profile

Sandoz Group AG is a Switzerland based company which is active in healthcare technology industry. The Company operates in two businesses, Generics and Biosimilars. Generics business develops, manufacture and market active ingredients and finished dosage forms of small molecule pharmaceuticals, finished dosage forms of anti-infectives and active pharmaceutical ingredients and intermediates. Biosimilars business develops, manufacture and market protein-based and other biological products which are similar to another already approved biological medicines. Company’s product portfolio comprising Generics and Biosimilars covers all therapeutic areas for patient treatment such as cardiovascular, central nervous system, oncology, anti-infectives, pain and respiratory. The Company serves customers worldwide.
Sector
-
More about the company

Ratings for Sandoz Group AG

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Consensus: Sandoz Group AG

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
15
Last Close Price
35.78 USD
Average target price
40.41 USD
Spread / Average Target
+12.94%
Consensus
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW